The effect of Phenobarbital on the duration of hospitalization in non-hemolytic neonatal jaundice
Phase 2
- Conditions
- eonatal jaundice.Neonatal jaundice, unspecified
- Registration Number
- IRCT2016052628090N1
- Lead Sponsor
- Qazvin University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 90
Inclusion Criteria
Term neonate (> 37 weeks); Weight >= 2500 g; Indirect hyperbilirubinemia (Total bilirubin level: 17-20 mg/dL); Indication for phototherapy
Exclusion criteria:
Hemolysis from any cause; Metabolic and endocrine disorders; Genetic or chromosomal disorders; Sepsis; Blood transfusions; Any previous traditional drug therapy or phototherapy ; Vitamin K deficiency or bleeding in newborns; History of taking vitamin K by the mother during pregnancy; Discharge of infants with personal consent of parents before completion of treatment; Lack of parental consent for treatment or study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Total serum bilirubin levels. Timepoint: before, 24 and 48 hours after the initiation of treatment. Method of measurement: Blood test.;Duration of hospitalization. Timepoint: Discharge time. Method of measurement: Patient file.
- Secondary Outcome Measures
Name Time Method